🔎 Trials Near Me

Home › Colon Cancer › Oklahoma › Oklahoma City

Colon Cancer clinical trials in Oklahoma City, OK

6 studies for Colon Cancer are looking for participants at sites in and around Oklahoma City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Family Communications After Genetic Testing

RecruitingHealthy volunteers welcome
  • Mercy Hospital Oklahoma City, Oklahoma City
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07143487

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

RecruitingHealthy volunteers welcome
  • Mercy Hospital Oklahoma City, Oklahoma City
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07283939

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RecruitingPhase 1/2
  • University of Oklahoma, Oklahoma City
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Recruiting
  • Veterans Administration Medical Center - Oklahoma City, Oklahoma City
  • Mercy Hospital Oklahoma City, Oklahoma City
Ages 45 to 70 · All sexes · Updated Sep 2, 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

RecruitingPhase 2/3
  • University of Oklahoma Health Sciences Center, Oklahoma City
  • Integris Southwest Medical Center, Oklahoma City
  • Mercy Hospital Oklahoma City, Oklahoma City
  • and 1 more
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05174169

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

RecruitingPhase 1
  • Xencor Investigative Site, Oklahoma City
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT05433142

Colon Cancer trials in other cities

Other studies in Oklahoma City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.